Insights

  • Date

  • Content Type

  • Reset

Blog

How our vaccines team supports innovation across global healthcare systems

8.11.22

By Michael Pfleiderer, PhD

Development of vaccines is a complex, evolving and highly specialized field that spans innovation, regulatory
Read More

Blog

Navigating the complex and evolving regulatory environment of 3D Printing

20.09.22

By Elena Meurer

Interest in manufacturing solutions that utilize 3D printing technology is constantly growing. Recently, 3D printing
Read More

Blog

On the acceleration of gene editing: what’s next?

20.09.22

By Tim Farries, PhD

A timely panel debate is coming, and Biopharma Excellence will be privileged to moderate it,
Read More

Blog

Getting the balance right with biosimilars

16.05.22

By Peter Lavrencic

As many of the top-selling biotech drugs face loss of patent in the next few years, a large number...
Read More

Blog

A Meeting of Minds: Cell & Gene Conference Brings Tight-Knit Community Together

16.05.22

By Emma Cheesman-Ungstrup | Liron Sarid-Krebs | Elena Meurer

After two years stuck at home and only able to attend virtual conferences, the 2022 Cell & Gene Meeting...
Read More

Blog

The dos and don’ts of scientific due diligence

12.04.22

By Dr. Diane Seimetz

Partnering, mergers and acquisitions, and product licensing require careful preparation, particularly when it comes to
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more